TOUCHSTONE INTERNATIONAL MEDICAL SCIENCE CO., LTD. Touchstone International Medical Science Co., Ltd. Stock
Equities
688013
CNE1000042J3
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.09 CNY | +2.78% |
|
+6.98% | -14.27% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 232M 32.14M | Sales 2023 | 254M 35.13M | Capitalization | 1.67B 231M |
|---|---|---|---|---|---|
| Net income 2022 | 43M 5.96M | Net income 2023 | 47M 6.51M | EV / Sales 2022 | 5.15 x |
| Net cash position 2022 | 361M 50.06M | Net cash position 2023 | 428M 59.3M | EV / Sales 2023 | 4.9 x |
| P/E ratio 2022 |
36.6
x | P/E ratio 2023 |
36.4
x | Employees | 231 |
| Yield 2022 |
1.29% | Yield 2023 |
-
| Free-Float | 37.04% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.78% | ||
| 1 week | +6.98% | ||
| Current month | +6.98% | ||
| 1 month | +7.10% | ||
| 3 months | +24.24% | ||
| 6 months | -20.06% | ||
| Current year | -14.27% |
1 week
17.00
18.18
1 month
13.9818.18
Current year
11.5621.76
1 year
11.5625.02
3 years
11.5634.28
5 years
11.5648.00
10 years
11.5648.00
| Managers | Title | Age | Since |
|---|---|---|---|
Wang Dong Chen
CEO | Chief Executive Officer | 54 | 19-11-07 |
Guo Yu Tian
DFI | Director of Finance/CFO | 45 | 22-09-25 |
Cai Hong Yang
BRD | Director/Board Member | 41 | 22-10-25 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wang Yu Chen
FOU | Founder | 58 | 03-08-17 |
Wang Dong Chen
CEO | Chief Executive Officer | 54 | 19-11-07 |
Jie Er Shen
CHM | Chairman | 73 | 14-09-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-08 | 18.09 | +2.78% | 588 329 |
| 24-05-08 | 17.6 | -0.51% | 432,073 |
| 24-05-07 | 17.69 | -0.06% | 471,496 |
| 24-05-06 | 17.7 | +4.67% | 1,101,364 |
| 24-04-30 | 16.91 | +0.42% | 1,158,768 |
End-of-day quote Shanghai S.E., May 08, 2024
More quotes
Touchstone International Medical Science Co Ltd is a China-based company mainly engaged in research, development, innovation, production and sales of high-end surgical staplers. The Company's products include tubular staplers, endoscopic staplers, linear cutting staplers, purse-string staplers and linear suture staplers. Its products are used in the surgical fields of cardiothoracic surgery, gastrointestinal surgery, hepatobiliary spleen and pancreatic surgery, general surgery and urology. The Company conducts its businesses within the China market and to overseas markets such as Italy, Spain, Austria, Brazil, South Korea, the United Kingdom and Australia.
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -14.27% | 193M | |
| +9.48% | 27.38B | |
| -30.22% | 3.08B | |
| -15.44% | 2.51B | |
| +18.49% | 2.45B | |
| +7.04% | 2.09B | |
| -4.11% | 2.05B | |
| +1.67% | 1.55B | |
| +0.59% | 1.29B | |
| +23.78% | 1.23B |
- Stock Market
- Equities
- 688013 Stock